Skip to content

Author

C. Fichtenbaum

We have 2 of 266 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Cancer incidence and risk factors among people with HIV in REPRIEVE.

OBJECTIVE Cancer is a leading cause of morbidity and mortality among people with HIV (PWH), who face a greater risk than the general population. An enhanced understanding of cancer incidence and associated risk factors among PWH receiving effective antiretroviral therapy (ART) may guide targeted preventive intervention...

Sophia H. Zhao, S. McCallum, Aya Awwad et al. · 0 citations
Clinical trial Open access Aug 2026

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

Findings highlight the need for improved screening and optimized treatment of hypertension in people with HIV and explore the relationship between hypertension and MACE using cause-specific Cox proportional hazards models.

Risa M. Hoffman, Maya Watanabe, E. Martínez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.